Cargando…

Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines

BACKGROUND: Although maintaining vaccines in a strict cold chain has cost and logistical implications in low- and middle-income countries, only a few vaccines have obtained approval for extended controlled temperature conditions (ECTC) application, which permits the administration of vaccines after...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Deok Ryun, You, Young Ae, Ahn, Hyeon Seon, Park, Eun Lyeong, Lim, Jacqueline KyungAh, Song, Katerina Rok, Chon, Yun, Lynch, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560890/
https://www.ncbi.nlm.nih.gov/pubmed/37741760
http://dx.doi.org/10.1016/j.vaccine.2023.08.012
_version_ 1785117819991490560
author Kim, Deok Ryun
You, Young Ae
Ahn, Hyeon Seon
Park, Eun Lyeong
Lim, Jacqueline KyungAh
Song, Katerina Rok
Chon, Yun
Lynch, Julia
author_facet Kim, Deok Ryun
You, Young Ae
Ahn, Hyeon Seon
Park, Eun Lyeong
Lim, Jacqueline KyungAh
Song, Katerina Rok
Chon, Yun
Lynch, Julia
author_sort Kim, Deok Ryun
collection PubMed
description BACKGROUND: Although maintaining vaccines in a strict cold chain has cost and logistical implications in low- and middle-income countries, only a few vaccines have obtained approval for extended controlled temperature conditions (ECTC) application, which permits the administration of vaccines after storage outside of the cold chain for a defined period. We developed a methodology to evaluate stability data and calculate minimum release potency (MRP) in support of ECTC application. METHODS: The methodology is focused on statistical considerations consisting of stability data collection, statistical analysis plan, statistical modelling, and statistical report. It uses mock stability data from a hypothetical product and may serve as a helpful guide for other products. The statistical data analysis is performed using the R program which is an open-source program and validated using the SAS software. RESULTS: We developed a stability data testing scheme that included 24 lots with six-time points for up to 24 months under real-time and real condition (RT) in the cold chain samples stored at 2–8 °C and 12 lots with six timepoints for 14 days under ECTC samples stored at 40 °C. The log-transformed stability data met the linear regression assumptions and were poolable from representative lots with no significant lot variation. The linear regression analysis model with a common slope and intercept confirmed the stable antigen content over time under RT and ECTC by the mean regression line and 95% confidence interval. Based on the fitted models and the estimated coefficients, the antigen content value of 966 was derived as the MRP under RT for 24 months followed by 14 days under ECTC. CONCLUSION: The presented framework of statistical considerations, with practical methods and R program codes to perform statistical analysis, may serve as a guide for developing the CTC data for a vaccine’s stability evaluation prospectively.
format Online
Article
Text
id pubmed-10560890
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-105608902023-10-10 Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines Kim, Deok Ryun You, Young Ae Ahn, Hyeon Seon Park, Eun Lyeong Lim, Jacqueline KyungAh Song, Katerina Rok Chon, Yun Lynch, Julia Vaccine Article BACKGROUND: Although maintaining vaccines in a strict cold chain has cost and logistical implications in low- and middle-income countries, only a few vaccines have obtained approval for extended controlled temperature conditions (ECTC) application, which permits the administration of vaccines after storage outside of the cold chain for a defined period. We developed a methodology to evaluate stability data and calculate minimum release potency (MRP) in support of ECTC application. METHODS: The methodology is focused on statistical considerations consisting of stability data collection, statistical analysis plan, statistical modelling, and statistical report. It uses mock stability data from a hypothetical product and may serve as a helpful guide for other products. The statistical data analysis is performed using the R program which is an open-source program and validated using the SAS software. RESULTS: We developed a stability data testing scheme that included 24 lots with six-time points for up to 24 months under real-time and real condition (RT) in the cold chain samples stored at 2–8 °C and 12 lots with six timepoints for 14 days under ECTC samples stored at 40 °C. The log-transformed stability data met the linear regression assumptions and were poolable from representative lots with no significant lot variation. The linear regression analysis model with a common slope and intercept confirmed the stable antigen content over time under RT and ECTC by the mean regression line and 95% confidence interval. Based on the fitted models and the estimated coefficients, the antigen content value of 966 was derived as the MRP under RT for 24 months followed by 14 days under ECTC. CONCLUSION: The presented framework of statistical considerations, with practical methods and R program codes to perform statistical analysis, may serve as a guide for developing the CTC data for a vaccine’s stability evaluation prospectively. Elsevier Science 2023-10-06 /pmc/articles/PMC10560890/ /pubmed/37741760 http://dx.doi.org/10.1016/j.vaccine.2023.08.012 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Deok Ryun
You, Young Ae
Ahn, Hyeon Seon
Park, Eun Lyeong
Lim, Jacqueline KyungAh
Song, Katerina Rok
Chon, Yun
Lynch, Julia
Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines
title Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines
title_full Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines
title_fullStr Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines
title_full_unstemmed Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines
title_short Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines
title_sort statistical considerations on real time and extended controlled temperature conditions (ectc) stability data analysis of vaccines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560890/
https://www.ncbi.nlm.nih.gov/pubmed/37741760
http://dx.doi.org/10.1016/j.vaccine.2023.08.012
work_keys_str_mv AT kimdeokryun statisticalconsiderationsonrealtimeandextendedcontrolledtemperatureconditionsectcstabilitydataanalysisofvaccines
AT youyoungae statisticalconsiderationsonrealtimeandextendedcontrolledtemperatureconditionsectcstabilitydataanalysisofvaccines
AT ahnhyeonseon statisticalconsiderationsonrealtimeandextendedcontrolledtemperatureconditionsectcstabilitydataanalysisofvaccines
AT parkeunlyeong statisticalconsiderationsonrealtimeandextendedcontrolledtemperatureconditionsectcstabilitydataanalysisofvaccines
AT limjacquelinekyungah statisticalconsiderationsonrealtimeandextendedcontrolledtemperatureconditionsectcstabilitydataanalysisofvaccines
AT songkaterinarok statisticalconsiderationsonrealtimeandextendedcontrolledtemperatureconditionsectcstabilitydataanalysisofvaccines
AT chonyun statisticalconsiderationsonrealtimeandextendedcontrolledtemperatureconditionsectcstabilitydataanalysisofvaccines
AT lynchjulia statisticalconsiderationsonrealtimeandextendedcontrolledtemperatureconditionsectcstabilitydataanalysisofvaccines